Trading of AVEO Common Stock Halted
FDA Advisory Committee To Review Tivozanib for the Treatment of Advanced Renal Cell Carcinoma
AVEO Conference Call Today at
Today’s Conference Call and Webcast Reminder
The AVEO management team will host a conference call today at
A webcast of the conference call can also be accessed by visiting the investors section of the AVEO website at investor.aveooncology.com. A replay of the webcast will be archived on the company’s website for two weeks following the call.
AVEO Oncology (NASDAQ: AVEO) is a cancer therapeutics company committed to discovering, developing and commercializing targeted therapies to impact patients’ lives. AVEO’s proprietary Human Response PlatformTM provides the company unique insights into cancer biology and is being leveraged in the discovery and clinical development of its cancer therapeutics. For more information, please visit the company’s website at www.aveooncology.com.
Source: AVEO Oncology
Caton Morris, 910-232-7166
Rob Kloppenburg, 617-930-5595
Dan Budwick, 973-271-6085